Table 2.
Study | Number of patients (n) | Age of patients (years) | PFO (cryptogenic) (%) | PFO (controls) (%) | P |
---|---|---|---|---|---|
Prevalence of PFO in young patients | |||||
Lechat[35] | 26 | <55 | 54 (14/26) | 10 (10/100) | <0.001 |
Webster[36] | 34 | <40 | 56 (19/34) | 15 (6/40) | <0.001 |
Cabanes[37] | 64 | <55 | 56 (36/64) | 18 (9/50) | <0.001 |
De Belder[38] | 39 | <55 | 13 (5/39) | 3 (1/39) | — |
Di Tullio[39] | 21 | <55 | 47 (10/21) | 4 (1/24) | <0.001 |
Hausmann[40] | 18 | <40 | 50 (9/18) | 11 (2/18) | <0.05 |
Handke[33] | 82 | <55 | 44 (36/82) | 14 (7/49) | <0.001 |
Total | 284 | 45 (129/284) | 11 (36/320) | <0.001 | |
Prevalence of PFO in old patients | |||||
De Belder[38] | 64 | >55 | 20 (13/64) | 5 (3/56) | <0.001 |
Di Tullio[39] | 24 | >55 | 38 (9/24) | 8 (6/77) | <0.001 |
Hausmann[40] | 20 | >40 | 15 (3/20) | 23 (23/98) | ns |
Jones[41] | 57 | >50 | 18 (10/57) | 16 (29/183) | ns |
Handke[33] | 145 | >55 | 28 (41/145) | 12 (28/232) | <0.001 |
Total | 310 | 25 (76/310) | 14 (89/646) | <0.001 |
PFO = Patent foramen ovale